These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
200 related items for PubMed ID: 27095779
41. A risk score for prediction of recurrence in patients with unprovoked venous thromboembolism (DAMOVES). Franco Moreno AI, García Navarro MJ, Ortiz Sánchez J, Martín Díaz RM, Madroñal Cerezo E, de Ancos Aracil CL, Cabello Clotet N, Perales Fraile I, Gimeno García S, Montero Hernández C, Zapatero Gaviria A, Ruiz Giardín JM. Eur J Intern Med; 2016 Apr; 29():59-64. PubMed ID: 26775136 [Abstract] [Full Text] [Related]
42. [Risk factors of pulmonary embolism in senile and non-senile inpatients and the predictive value of Caprini risk assessment model in these two populations]. Chen Y, Zhou HX, Hu YH, Cong TX, Tang YJ, Wang L, Wang MY, Yi Q, Liang ZA. Zhonghua Yi Xue Za Zhi; 2017 Mar 14; 97(10):755-760. PubMed ID: 28316156 [Abstract] [Full Text] [Related]
43. Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice. Kaatz S, Fu AC, AbuDagga A, LaMori J, Bookhart BK, Damaraju CV, Tan H, Schein J, Nutescu E. Thromb Res; 2014 Oct 14; 134(4):807-13. PubMed ID: 25127013 [Abstract] [Full Text] [Related]
44. Mortality and recurrence after treatment of VTE: long term follow-up of patients with good life-expectancy. Andresen MS, Sandven I, Brunborg C, Njaastad AM, Strekerud F, Abdelnoor M, Smith P, Abildgaard U. Thromb Res; 2011 Jun 14; 127(6):540-6. PubMed ID: 21435698 [Abstract] [Full Text] [Related]
45. Use of statins and reduced risk of recurrence of VTE in an older population. A population-based cohort study. Tagalakis V, Eberg M, Kahn S, Azoulay L. Thromb Haemost; 2016 Jun 02; 115(6):1220-8. PubMed ID: 26819144 [Abstract] [Full Text] [Related]
46. Duration of anticoagulant therapy and VTE recurrence in patients with cancer. Khorana AA, McCrae KR, Milentijevic D, Fortier J, Nelson WW, Laliberté F, Crivera C, Lefebvre P, Schein J. Support Care Cancer; 2019 Oct 02; 27(10):3833-3840. PubMed ID: 30734088 [Abstract] [Full Text] [Related]
47. Red cell distribution width is associated with incident venous thromboembolism (VTE) and case-fatality after VTE in a general population. Ellingsen TS, Lappegård J, Skjelbakken T, Brækkan SK, Hansen JB. Thromb Haemost; 2015 Jan 02; 113(1):193-200. PubMed ID: 25274492 [Abstract] [Full Text] [Related]
48. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials. van Doormaal FF, Raskob GE, Davidson BL, Decousus H, Gallus A, Lensing AW, Piovella F, Prins MH, Büller HR. Thromb Haemost; 2009 Apr 02; 101(4):762-9. PubMed ID: 19350123 [Abstract] [Full Text] [Related]
49. Development of a predictive model of venous thromboembolism recurrence in anticoagulated cancer patients using machine learning. Muñoz AJ, Souto JC, Lecumberri R, Obispo B, Sanchez A, Aparicio J, Aguayo C, Gutierrez D, Palomo AG, Fanjul V, Del Rio-Bermudez C, Viñuela-Benéitez MC, Hernández-Presa MÁ. Thromb Res; 2023 Aug 02; 228():181-188. PubMed ID: 37348318 [Abstract] [Full Text] [Related]
50. Risk stratifying emergency department patients with acute pulmonary embolism: Does the simplified Pulmonary Embolism Severity Index perform as well as the original? Vinson DR, Ballard DW, Mark DG, Huang J, Reed ME, Rauchwerger AS, Wang DH, Lin JS, Kene MV, Pleshakov TS, Sax DK, Sax JM, McLachlan DI, Yamin CK, Swap CJ, Iskin HR, Vemula R, Fleming BS, Elms AR, Aujesky D, MAPLE investigators of the KP CREST Network. Thromb Res; 2016 Dec 02; 148():1-8. PubMed ID: 27764729 [Abstract] [Full Text] [Related]
51. Value of D-dimer testing for the exclusion of pulmonary embolism in patients with previous venous thromboembolism. Le Gal G, Righini M, Roy PM, Sanchez O, Aujesky D, Perrier A, Bounameaux H. Arch Intern Med; 2006 Jan 23; 166(2):176-80. PubMed ID: 16432085 [Abstract] [Full Text] [Related]
52. Association between serum calcium and prognosis in patients with acute pulmonary embolism and the optimization of pulmonary embolism severity index. Wang X, Xiang Y, Zhang T, Yang Y, Sun X, Shi J. Respir Res; 2020 Nov 11; 21(1):298. PubMed ID: 33176778 [Abstract] [Full Text] [Related]
53. Rivaroxaban for the treatment of venous thromboembolism. A "real-life" perspective in 103 patients. Jara-Palomares L, Sanchez-Oro-Gomez R, Elias-Hernandez T, Morillo-Guerrero R, Ferrer-Galvan M, Asensio-Cruz MI, Barrot-Cortes E, Otero-Candelera R. Thromb Res; 2014 Sep 11; 134(3):617-21. PubMed ID: 25034320 [Abstract] [Full Text] [Related]
54. Thromboembolism After Intramedullary Nailing for Metastatic Bone Lesions. Shallop B, Starks A, Greenbaum S, Geller DS, Lee A, Ready J, Merli G, Maltenfort M, Abraham JA. J Bone Joint Surg Am; 2015 Sep 16; 97(18):1503-11. PubMed ID: 26378266 [Abstract] [Full Text] [Related]
55. Short- and long-term mortality after pulmonary embolism in patients with and without cancer. Alotaibi G, Wu C, Senthilselvan A, McMurtry MS. Vasc Med; 2018 Jun 16; 23(3):261-266. PubMed ID: 29521183 [Abstract] [Full Text] [Related]
56. Signs and Symptoms of Venous Thromboembolism and Survival Outcome of Endometrial Cancer. Machida H, Hom MS, Maeda M, Yeo JJ, Ghattas CS, Grubbs BH, Matsuo K. Int J Gynecol Cancer; 2016 Jun 16; 26(5):924-32. PubMed ID: 27051051 [Abstract] [Full Text] [Related]
58. External validation of a claims-based and clinical approach for predicting post-pulmonary embolism outcomes among United States veterans. Kohn CG, Weeda ER, Kumar N, Wells PS, Peacock WF, Fermann GJ, Wang L, Baser O, Schein JR, Crivera C, Coleman CI. Intern Emerg Med; 2017 Aug 16; 12(5):613-619. PubMed ID: 28185131 [Abstract] [Full Text] [Related]
59. Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study. Cohen AT, Katholing A, Rietbrock S, Bamber L, Martinez C. Thromb Haemost; 2017 Jan 05; 117(1):57-65. PubMed ID: 27709226 [Abstract] [Full Text] [Related]